Business Context and Reporting Period
This Form 8-K was filed by AmerisourceBergen Corporation (now Cencora, Inc.) on June 23, 2016, reporting events occurring on June 21 and June 22, 2016. The filing details amendments to the company's securitization facility and a subsequent debt prepayment.
Key Financial Metrics and Liquidity
- Securitization Facility Limit: Increased by $500 million to a base limit of $1,450 million.
- Seasonal Expansion Option: An additional $250 million is available for seasonal needs during December and March quarters, subject to bank approval.
- Debt Prepayment: On June 22, 2016, the company prepaid $500 million on its Term Loan Credit Agreement using proceeds from the securitization facility.
- Liquidity Source: The facility is secured by accounts receivable originated from the sale of pharmaceuticals and related services.
Material Changes
The primary material change is the expansion of the company's liquidity capacity through the Tenth Amendment to the Receivables Purchase Agreement. Key changes include:
- Assignment of 100% of Working Capital Management Co., LP's commitment to Mizuho Bank, Ltd.
- Joining of Advantage Asset Securitization Corp. as an uncommitted purchaser.
- Conformity of covenants and definitions with the company's multi-currency revolving credit facility.
Management Commentary and Risks
The amendments were executed to provide additional liquidity and funding for ongoing business needs. The Registrant serves as the performance guarantor for the obligations of its subsidiary, AmerisourceBergen Drug Corporation (ABDC), under the facility. The filing notes that the description of the amendments is qualified by reference to the full legal agreements filed as exhibits.
Investor Verification Checklist
- Verify the total available liquidity under the amended securitization facility ($1,450 million base + $250 million seasonal option).
- Confirm the impact of the $500 million term loan prepayment on the company's overall debt maturity profile.
- Review the full text of Exhibit 10.1 (Tenth Amendment) and Exhibit 10.2 (Fifth Amendment) for specific covenant details and amortization events.
- Assess the concentration of risk regarding Mizuho Bank, Ltd. as the assignee of the full commitment previously held by Working Capital.